20
Quantified Others How to make the most out of Quantified Self QS Europe 2013

Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

Embed Size (px)

DESCRIPTION

Ignite talk at Quantified Self Europe, 2013 in Amsterdam. We report on a collaboration that started at QS Europe 2011 to led to us building tracking tools for people with Parkinson's Disease.

Citation preview

Page 1: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

QuantifiedOthers

How to make the mostout of Quantified Self

QS Europe 2013

Page 2: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

Previously on Quantified

Self Europe…

QS Europe 2011

Page 3: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

Image by Sebastiaan ter Burg

Page 4: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 5: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 6: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 7: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 8: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

LONDON

https://vimeo.com/36278484

Page 9: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

Strategic Business Research Initiative (SBRI)

1 2

Page 10: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

Strategic Business Research Initiative (SBRI)

1 2

Page 11: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 12: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 13: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 14: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 15: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

2.7

2.8

2.9

3

3.1

3.2

3.3

3.4

3.5

START END

Ave

rage

Se

lf R

atin

g

Energy scores

FULL APP

LIMITED APP

Trial: 41 recruited,

26 used application,

16 completed de-briefing

• Showed a marginally significant

improvement in the self -reported

Meds rating (p<0.15)

• Significant improvements in

health behaviours scores in both

groups

• Indicates potential to improve

medication adherence / compliance

70%Daily use during 2

month trial period

“Excellent in conception and ease of use”

“I find it very attractive & extremely easy to use”

Patient Feedback:

Page 16: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

Phase 2 - FUNDED

300 patient multi-centre test lasting 6 months

Suvankar Pal,

Rowling Centre and Forth

Valley

Mo Albazzaz,

Barnsley

Hospital

Ben Chico,

Rotherham

Ray Chaudhuri,

Kings College

Julian Fearnley,

Barts and The Royal

London

Beverly Castleton,

St Peter’s Hospital,

Surrey

Andrew Fowlie,

NHS Grampian

Max Little,

Aston University

Page 17: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 18: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013
Page 19: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013

QS images by Henk-Jan Winkeldermaat, Punkmedia.nl

Page 20: Quantified Others - Sara Riggare & Caspar Addyman Ignite QS Europe 2013